- Home
- VYGR vs POWW Comparison
VYGR vs POWW Comparison
Compare VYGR & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- POWW
- Stock Information
- Founded
- VYGR 2013
- POWW 1990
- Country
- VYGR United States
- POWW United States
- Employees
- VYGR N/A
- POWW N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- POWW Ordnance And Accessories
- Sector
- VYGR Health Care
- POWW Industrials
- Exchange
- VYGR Nasdaq
- POWW Nasdaq
- Market Cap
- VYGR 191.9M
- POWW 219.7M
- IPO Year
- VYGR 2015
- POWW N/A
- Fundamental
- Price
- VYGR $3.17
- POWW $1.99
- Analyst Decision
- VYGR Strong Buy
- POWW Hold
- Analyst Count
- VYGR 9
- POWW 1
- Target Price
- VYGR $14.86
- POWW $1.50
- AVG Volume (30 Days)
- VYGR 282.0K
- POWW 584.8K
- Earning Date
- VYGR 05-06-2025
- POWW 06-12-2025
- Dividend Yield
- VYGR N/A
- POWW N/A
- EPS Growth
- VYGR N/A
- POWW N/A
- EPS
- VYGR N/A
- POWW N/A
- Revenue
- VYGR $66,958,000.00
- POWW $135,498,023.00
- Revenue This Year
- VYGR N/A
- POWW $5.67
- Revenue Next Year
- VYGR $2.04
- POWW N/A
- P/E Ratio
- VYGR N/A
- POWW N/A
- Revenue Growth
- VYGR N/A
- POWW N/A
- 52 Week Low
- VYGR $2.75
- POWW $0.95
- 52 Week High
- VYGR $9.55
- POWW $2.86
- Technical
- Relative Strength Index (RSI)
- VYGR 40.49
- POWW 67.78
- Support Level
- VYGR $3.46
- POWW $1.93
- Resistance Level
- VYGR $3.69
- POWW $2.05
- Average True Range (ATR)
- VYGR 0.18
- POWW 0.12
- MACD
- VYGR 0.00
- POWW 0.02
- Stochastic Oscillator
- VYGR 0.00
- POWW 75.86
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About POWW AMMO Inc.
AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.